Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE), and nonfermenting Gram-negative bacilli, including Pseudomonas aerug...

Descripción completa

Detalles Bibliográficos
Autores principales: Rolston, Kenneth V. I., Gerges, Baghat, Shelburne, Samuel, Aitken, Samuel L., Raad, Issam, Prince, Randall A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179642/
https://www.ncbi.nlm.nih.gov/pubmed/32071053
http://dx.doi.org/10.1128/AAC.01955-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7179642/
https://www.ncbi.nlm.nih.gov/pubmed/32071053
http://dx.doi.org/10.1128/AAC.01955-19

Ejemplares similares